Table 3 Disease recurrence according to the risk assessed according to ATA Guidelines [4], [18F]FDG PET/CT findings and PSMA expression
Disease recurrence | Risk of structural disease recurrence according to ATA Guidelines [4] | [18F]FDG PET/CT (n = 23) | ||
|---|---|---|---|---|
Negative (n = 12) | Positive (n = 11) | |||
PSMA negative (n = 6) | PSMA positive (n = 6) | PSMA positive (n = 11) | ||
Yes (n = 18) | Low | n = 0 | n = 0 | n = 2 |
Intermediate | n = 1 | n = 1 | n = 0 | |
High | n = 2 | n = 2 | n = 6 | |
Not assessable | n = 0 | n = 1 | n = 3 | |
No (n = 5) | Low | n = 0 | n = 0 | n = 0 |
Intermediate | n = 3 | n = 1 | n = 0 | |
High | n = 0 | n = 1 | n = 0 | |
Not assessable | n = 0 | n = 0 | n = 0 | |